Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents - Concepedia

Concepedia

Publication | Open Access

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

DOI Full Paper Access

670

Citations

27

References

2013

Year

Hui Yang, Carlos E. Bueso‐Ramos, Courtney DiNardo, Marcos R. Estecio, Masoud Davanlou, Qi-Rong Geng, Zhihong Fang, Martin Nguyen, Sherry Pierce, Yue Wei,

Hematological MalignancyBone Marrow FailureHematologyImmunologyPathologyMedicineMyelodysplastic SyndromesMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1